NP Generic Medicines Transition Tender (October 2023)
This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into four (4) individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£4,972,000
Published
26 Sept 2023
Closes
14 Aug 2023
Procurement details
Source
Find a Tender
Region
Scotland
Procurement method
Open
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 3 NP40923a Sugammadex
£2,539,833
Supply of Sugammadex solution for injection vials, in a range of presentations to NHS Scotland. The Authority will be awarding each line to a single Framework Participant within the single supplier Framework Agreement.
Delivery: Scotland
Lot 4 NP36123a Atovaquone
£226,333
Supply of Atovaquone 750mg/5ml oral suspension sugar free to NHS Scotland. The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.
Delivery: Scotland
Lot 1 NP35923a Apixaban
£2,119,925
Supply of Apixaban tablets in a range of presentations. The Authority will be awarding each product line as a multi-supplier unranked framework agreement to five (5) suppliers awarded to each line.
Delivery: Scotland
Lot 2 NP39723a Bexarotene
£85,900
Supply of Bexarotene 75mg capsules to NHS Scotland. The Authority will be awarding the product line to a single Framework Participant within the single supplier Framework Agreement.
Delivery: Scotland
Documents
No document metadata is available for this public record.
Contains public sector information licensed under the Open Government Licence v3.0.